Por favor, use este identificador para citar o enlazar este ítem:
https://doi.org/10.1093/jac/dks019.
Twittear
Título: | Epidemiology, species dsitribution and in vitro antifungal susceptibility of fungemia in a Spanish multicenter prospective survey |
Fecha de publicación: | may-2012 |
Cita bibliográfica: | Journal of Antimicrobial Chemotherapy, 2012 May;67(5):1181-1187. |
ISSN: | Print: 0305-7453 Electronic: 1460-2091 |
Palabras clave: | Fungemia Epidemiologia Sensibilidad Especies España |
Resumen: | Objectives: To update the knowledge of the epidemiology of fungaemia episodes in Spain, the species implicated and their in vitro antifungal susceptibilities. Methods: Episodes were identified prospectively over 13 months at 44 hospitals. Molecular methods were used to determine the cryptic species inside the Candida parapsilosis and Candida glabrata complexes. Susceptibility to amphotericin B, anidulafungin, caspofungin, fluconazole, flucytosine, itraconazole, micafungin, posaconazole and voriconazole was determined by a microdilution colorimetric method. New species-specific clinical breakpoints (SSCBPs) for echinocandins, fluconazole and voriconazole were applied. Results: The incidence of the 1357 fungaemia episodes evaluated was 0.92 per 1000 admissions. The incidence of Candida albicans fungaemia was the highest (0.41 episodes/1000 admissions), followed by Candida parapsilosis sensu stricto (0.22). Candida orthopsilosis was the fifth cause of fungaemia (0.02), outnumbered by Candida glabrata and Candida tropicalis. Interestingly, the incidence of fungaemia by C. parapsilosis was 11 and 74 times higher than that by C. orthopsilosis and Candida metapsilosis, respectively. Neither Candida nivariensis nor Candida bracarensis was isolated. Fungaemia was more common in non-intensive care unit settings (65.2%) and among elderly patients (46.4%), mixed fungaemia being incidental (1.5%). Overall susceptibility rates were 77.6% for itraconazole, 91.9% for fluconazole and 96.5%-99.8% for the other agents. Important resistance rates were only observed in C. glabrata for itraconazole (24.1%) and posaconazole (14.5%), and in Candida krusei for itraconazole (81.5%). Conclusions: Fungaemia is more common in non-critical patients. C. albicans is the most common species, followed by C. parapsilosis and C. glabrata. Nearly 90% of yeasts are susceptible to all antifungal agents tested. Resistance rates change moderately when applying the new SSCBPs. |
Autor/es principal/es: | Pemán, Javier Cantón, Emilia Quindós, Guillermo Eraso, Elena Alcoba, Julia Guinea, Jesús Merino, Paloma Ruiz-Pérez de Pipaon, María Teresa Pérez del Molino, Luisa Linares-Sicilia, María José Marco, Francesc García, Julio Roselló, Eva María Gómez-G-de-la-Pedrosa, Elia Borrell, Nuria Porras, Aurelio Yagüe, Genoveva |
URI: | http://hdl.handle.net/10201/138688 |
DOI: | https://doi.org/10.1093/jac/dks019. |
Tipo de documento: | info:eu-repo/semantics/article |
Número páginas / Extensión: | 6 |
Derechos: | info:eu-repo/semantics/embargoedAccess |
Aparece en las colecciones: | Artículos: Genética y Microbiología |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Pemán J, 2012;67-1181-7 (2).pdf | 197,26 kB | Adobe PDF | Visualizar/Abrir Solicitar una copia |
Los ítems de Digitum están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.